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INTRODUCTION 
1.1 Introductoin & Dibenzofuran 
 
 The Chemistry of heterocyclic compound is one of the most complex branches of 
Chemistry. Heterocyclic compounds are widely distributed in the nature and play an 
important role in regulating biological processes. A large number of heterocyclic compounds 
are as chemotherapeutic agent, drugs, dyestuffs and copolymers. Among these benzofuran is 
very interesting class of oxygen containing heterocyclic compounds having wide range of 
application in medicinal of synthetic chemistry.  
 The benzofuran nucleus ae have considerable importance as pharmaceuticals, 
insecticides, it occur in coaltar & are isolated as picrates. It also synthesis via palladium 
protonated cyclization of O-substituted aryl aryl ether. Many synthetic benzofuran 
derivatives have interesting properties. These are further used as intermediates for the 
preparation of herbicides, fungicides & parasiticides. 
O
 
 Condensation of a benzene ring with furan to form benzofuran & depending on 
whether the benzene ring is condensed at the 2,3 (or) 3,4 position. The first one is known as 
coumaran (or) benzofuran and the later is known as isocoumaran or isobenzofuran. 
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Among the other fused benzofuran derivatives furocoumarin, dibenzofurans and 
pyranobenzofuran are important class of oganic compounds. Particularly the dibenzofuran is 
somewhat confusing because of different systems of numbering employed by chemical 
abstracts prior to 1937.  
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Due to these divergent systems considerable care must be taken when consulting the 
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literature to ascertain the method of numbering. Benzofuran possessing various biological 
activities, particularly the dibenzofurans are reported to have analgesics, antiviral, anti-
inflammatory, coughinhibiting, hypolipemics and herbicidal properties. 
Thomas et al reported the synthesis of anticholestamic, dibenzofurnyl, N-alkyl 
carbamates and a new synthesis of novel dibenzofuran and two new xanthones from 
calophyllum panciflorum has been reported. 
 
Introduction of Anti-inflammatory activity 
 
 
Inflammation & Cell-Mediated Immune Response 
 
 
"Inflammation is the reaction of vascular supporting elements to injury and results in 
formation of protein rich exudates provided the injury has not been so serious as to 
destroy the area". Inflammation is one of the most important mechanisms involved in the 
each disease.  Inflammation is manifest by pain, swelling, redness, and loss of function in 
the affected tissue.  The  process  is  created  by  immune  cells invading the  tissue like  
an  army in  full  battle  mode.  Cell-mediated immunity is initiated by several cell 
populations, including mast cells, macrophages, eosinophils, and neutrophils. The net 
effect of sustained immune activity in any target organ is inflammation  with  local  
dysfunction,  associated  with  systemic  symptoms  from immune mediators released into 
the bloodstream. And create systemic symptoms by mediator or mediator release 
(Venkateshwaramurthi N 2010). 
 
                            Fig-1: Different Stages Involved in Anti-inflammatory Cycle 
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Antibodies 
 
 
The bone marrow is the major manufacturing area for immune cells. Some bone 
marrow cells migrate to the thymus gland and mature into T-lymphocytes. B- lymphocytes 
produce antibodies which identify specific foreign molecules and cell- surface markers and 
act against them. Immunity means that immune cells remember the identity of an antigen 
and initiate a defensive response. Antibodies are serum proteins or immunoglobulin. These 
proteins comprise of a memory system which detects antigens and then links antigens to an 
effecter system that defends against the antigen and associated structures. Antibodies are 
secreted by B-lymphocytes (transformed to plasma cells in tissue spaces). Antibodies may 
be free-floating in the blood and combine with antigen to form immune complexes 
(Masirkar J et al 2008). 
 
 
B-Lymphocytes originate in the bone marrow and migrate to lymphatic tissues 
throughout the body. The main sites of serum antibody production are the spleen, lymph 
nodes and mucosa associated lymphatic tissues.  In  young children, serum 
immunoglobulin increase in concentration and variety as they grow an indication of 
expanding acquired immunity and hypersensitivity to a variety of potential antigens that 
arrive from the environment (Meena AK et al 2010). 
 
There are 5 main antibody types: 
 
 
  IgA:  circulating  and  secreted  on  all  defended  body  surfaces,  as  the  first 
defense against invaders. 
  IgD: surface receptors on lymphocytes. 
 
  IgE:    the    antibody    which    produces    typical    allergy    or    immediate 
hypersensitivity reactions such hay fever, asthma, hives, and anaphylaxis. 
  IgG:  is  the  major  circulating  antibody  which  enters  tissues  freely,  and 
participates in diverse immune events. 
  IgM: the multivalent antibody, capable of capturing and binding antigens to 
form large insoluble complexes which are readily cleared from the blood. 
 
Lymphocytes 
 
 
Two major groups of lymphocytes are recognized as Thymus dependent or T- 
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lymphocytes; and Bursa dependent or B-lymphocytes. Adaptive immune responses 
require   B   cells   to   provide   antibody   and   T   cells   to   provide   cell-mediated 
immunity.  Cell surface receptors recognize antigens, B-lymphocytes learn make antibodies 
to specific antigens. Although T and B cells share a common progenitor, their development 
occurs in different locations in the body. B cells develop in the bone marrow and 
mature in lymphoid tissue. T lymphocyte progenitors leave the bone narrow and travel to 
the thymus where they mature (Vinothkumar et al 2009). 
 
 
The identity of a foreign molecule, microorganism or cell, is recognized by an 
antigenic determinant, an amino acid sequence, usually contained in an intact protein. Once 
an antigenic determinant is recognized, its sequence is remembered by clones of antigen-
specific B and T-memory cells which can activate other B lymphocytes that make 
antibodies against the antigen.  T memory cells are also referred to a as helper T cells 
which are activated by the binding of a specific antigen encountered in the past, a signal 
that initiates defense against familiar pathogens(Krishnaswamy NR 2003). 
 
 
Four cardinal signs of Inflammation: 
 
 
    Calor  - heat 
 
    Rubor  - redness 
 
    Tumor - swelling 
 
    Dolor  - pain 
 
 
Purpose of Immune Response: 
 
 
A.  Isolate, neutralize and remove cause of injury 
 
B.  Clear area of debris 
 
C.  Initiate healing and repair of injured tissue 
 
CLASSIFICATIONS 
 
Inflammation can be classified as 
 
 
    Acute inflammation 
 
    Chronic 
 
Acute inflammation: 
 
 
Acute inflammation is the initial response of the body to harmful stimuli and is 
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achieved by the increased movement of plasma and leukocytes from the blood in to the 
injured tissues. A cascade of biochemical events propagates and matures the 
inflammatory response, involving the local vascular system, the immune system, and 
various cells with in the injured tissue. Acute inflammation is a short-term process, usually 
appearing within a few minutes, hours or one or two days and ceasing upon the removal 
of the injurious stimulus (Jayakar B 2010). 
 
The cardinal signs are produced by 
 
 
i.   Changes in vascular flow 
 
ii.   Changes in vascular permeability 
 
iii. Cellular events – Leucocytes exudation and phagocytes 
 
 
 
 
                                                     Fig 2: Mechanism of Acute inflammation 
 
Chronic inflammation: 
 
 
Prolonged inflammation is known as chronic inflammation, known as chronic 
inflammation, leads to a progressive shift in the type of cells which are present at the site of 
inflammation and is characterized by simultaneous destruction and healing of the tissue 
from the inflammatory process. It is of longer duration and is associated with  presesnce  
of  lymphocytes,  macrophages,  proliferation  of  blood  vessels  and connective tissue.  
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The causes of chronic inflammation are 
 
 
i.   Progression of acute inflammation 
 
ii.   Repeated bouts of acute inflammation 
 
iii.   Insidious low grade smoldering response 
 
 
ANTI-INFLAMMATORY ACTIVITY: 
 
 
Anti-inflammatory refers to the property of a substance or treatment that reduces 
inflammation. Anti-inflammatory drugs make up about half of analgesics, remedying pain 
by reducing inflammation as opposed to opioids which affect the central nervous system.  
Anti-inflammatory medications are often used to treat medical conditions that cause 
swelling or inflammation in various areas of the body. Some of these medical conditions 
may include pulled muscles, arthritis, or lupus. Anti-inflammatory medications are 
available both with and without a prescription (Mohammed Ali 2001). 
 
 
Medications: 
 
 
1.   Steroids 
 
Steroid medications such as cortisone are man-made or synthetic versions  of 
natural hormones produced by the human body. These medications are often prescribed as 
anti-inflammatory medications. Steroid creams or ointments are often used externally to 
reduce swelling and inflammation associated with muscle, skin, or joint issues. Cortisone 
injections may be given by a doctor for deeper muscle or joint problems, including 
conditions such as arthritis. Many steroids, specifically glucocorticoids, reduce  
inflammation  or  swelling  by  binding  to  glucocorticoid receptors. These drugs are 
often referred to as corticosteroids (Kokate CK 2001). 
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Non-steroidal anti-inflammatory drugs: 
 
 
Non-steroidal anti-inflammatory drugs, commonly referred to as NSAIDs, are 
the most commonly prescribed anti-inflammatory medications for conditions such 
as arthritis and muscle pain. Many of these medications are available over the 
counter and can be found in most drug stores. Non-steroidal anti-inflammatory drugs 
(NSAIDs) alleviate pain by counteracting the cyclooxygenase (COX) enzyme. On 
its own COX enzyme synthesizes prostaglandins, creating inflammation. In whole 
the NSAIDs prevent the prostaglandins from ever being synthesized, reducing or 
eliminating the pain. Some common examples of NSAIDs include aspirin, 
ibuprofen, and  naproxen.  The  newer  specific  COX-inhibitors,  although  
probably  sharing  a similar mode of action, are not classified together with the 
traditional NSAIDs. 
 
 
On the other hand, there are analgesics that are commonly associated with anti- 
inflammatory drugs but that have no anti-inflammatory effects. An example is 
paracetamol, called acetaminophen in the U.S. and sold under the brand name of 
Tylenol. As opposed to NSAIDS, which reduce pain and inflammation by inhibiting 
COX enzymes, paracetamol has recently been shown to block the reuptake of 
cannabinoids. And which only reduces pain, likely explaining why it has 
minimal effect on inflammation.(Ashok D et al 2017). 
 
 
2.   Immune Selective Anti-Inflammatory Derivatives (ImSAIDs): 
 
 
Early work in this area demonstrated that the submandibular gland released a 
host  of  factors  which  regulate  systemic  inflammatory  responses  and  modulate 
systemic  immune  and  inflammatory  reactions.  It  is  now  well  accepted  that  
the immune, nervous and endocrine systems communicate and interact to control and 
modulate inflammation and tissue repair. One of the neuroendocrine pathways, when 
activated, results in the release of immune regulating peptides from the 
submandibular gland upon neuronal stimulation from sympathetic nerves. This 
pathway or communication is referred to as the cervical sympathetic trunk-
submandibular gland (CST-SMG) axis, a regulatory system that plays a role in 
the systemic control of inflammation. 
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1.4. CLASSIFICATION OF ANTI-INFLAMMATORY DRUGS 
 
1. Chemical Classification 
A: Salicylates 
- Acetyl salicylic acid (aspirin) 
- Sodium Salicylates 
- Choline Salicylates, 
- Sodium thio Salicylates 
- Salicylic Salicylates 
 
 
B: Propionic Acid Derivatives 
- Ibuprofen 
- Ketoprofen 
- Naproxen 
- Oxaprozin 
- Flurbiprofen 
 
 
C: Indole Acetic Acid 
- Indomethacin 
- Sulindac 
 
 
D: Substituted Anthranilic Acids (Rarely Used) 
- Mefenamic acid 
- Meclofenamate Na 
 
 
E: Pyrrole Alkanoic Acid (Rarely Used) 
- Tolmetin 
 
 
F: Oxicams 
- Piroxicam 
- Meloxicam 
 
 
G: Di-fluoro phenyl Derivatives 
- Diflunisal 
 
 
H: Phenyl Acetic Acid 
- Diclofenac 
 
 
I: Acetic Acid Derivatives 
- Etodolac 
 
 
J: Naphthyl Acetic Acid Prodrugs 
- Nabumetone 
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K: Para-Amino Phenol Derivatives 
- Acetaminophen 
 
 
2. According To Mechanism Of Action 
 
A: Non-Selective Cox Inhibitors 
- Diclofenac 
- Etodolac 
- Indomethacin 
- Ketoprofen 
- Ketorolac 
- Naproxen 
- 
Oxap
rozin 
- Ibuprofen 
- Flurbiprofen 
- Diflunisol 
- Piroxicam 
- Sulindac 
(Tenoxicam, Tiattrofin, Tolmetin are rarely used and not available in USA) 
 
 
B: Drugs More Effective Inhibitors of Cox-1 
- Aspirin 
- Indomethacin 
- Piroxicam 
- Sulindac 
 
C: Cox-2 Selective Inhibitors 
- Celecoxib 
- Etoricoxib 
- Meloxicam 
 
 
3. Therapeutic Classification 
 
A: Analgesics 
     - Aspirin 
   - Paracetamol 
 
 
B: AntiInflammatory 
- Indomethacin 
- Naproxen 
- Ibuprofen 
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C: Anti-Coagulants 
- Aspirin 
 
 
D: Anti-Pyretics 
- Aspirin 
- Paracetamol 
- Indomethacin 
- Celecoxib 
- Ibuprofen 
 
 
E: Inflammatory Bowel Disease 
- Sulfasalazine 
- Infiximab 
 
 
F: Anti-Cancer Drugs 
- 
Methotr
exate 
 
 
G: Anti-Malarial 
- Chloroquine 
- Hydroxychloroquine 
 
 
H: Tissue Transplantation 
- Cyclosporine 
 
 
I: Chelating Agents in Wilson’s disease 
- Penicillamine 
 
 
J: Anti-Gout Drugs 
- Indomethacin 
- Ibuprofen 
 
 
4. WHO Classification: 
 
A: Drugs with Weak Anti-Inflammatory Effect 
- 
Acetamino
phen 
 
 
B: Drugs with Mild to Moderate Anti-Inflammatory Effect 
- Propionic acid derivatives 
- Anthranilic acid derivatives 
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C: Drugs with Marked Anti-Inflammatory Effects 
- Salicylates, acetic acid derivatives 
- Oxicams 
- Diclofenac 
- Etodolac 
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Literature review 
Ji young cho et al (2018) has been synthesized dibenzofuran derivatives via intra 
molecular C-O bond formation. This involves the in situ production of a diazonium salt. 
OHNH2
O
Photocatalyst
nitrile source
Visible light 
        rt
 
Ying Ma et al (2017) was performed the synthesis, bioactivity, 3D QSAR studies 
of novel dibenzofuran derivatives as PTP-MEG2 inhibitors. His finding provides a new 
strategy as useful insights for designing the effective PTP-MEG2 inhibitor. 
OF
CH3
CH3
AcO
O
O
CH3 
Ashok D et al (2017) has reported the synthesis, biological evaluation of 
spirofurochromanone derivative as anti-inflammatory and antioxidant activity. They 
found certain compounds have better anti-inflammatory activity in the albumin 
denaturation technique. 
Ananthi R et al (2016) worked on antimicrobial and anti-inflammatroy activity of 
usnic acid and its acetyl derivative usnic acid diacetate. they concluded that the parent 
compound usnic acid was more active than usnic acid acetate. 
Gopalan B et al (2016) reported the synthesis of a few dibenzo(b,d) furan thiazole 
derivatives and exhibit promising in vitro PDE-4B and TNF- α inhibitor activities with 
promising result. 
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O
R
CSNH2
O
F  
Zhen liang et al (2016) has designed and synthesized a series of benzofuran 
triazole hybrids. The target compounds were evaluated in vitro antifungal activity. They 
found the results indicated that the compounds exhibited moderate to satisfactory activity. 
N
R2
N
N
O
O
CH3
O
F
R1
 
Thirumal Y et al (2014) has been reported a series of novel dibenzo(b,d)furan-
1,2,3-triazole conjugate and evaluate the invitro antimycobacterial activity against 
mycobacterium tuberculosis H37Rv(ATCC27294) showed most promosing 
antitubercular agent with lowest cytotoxicity. 
O
N
N
N
O
O
CH3
 
Lan –Xiang liu et al (2013) has been prepared a noval hybrid compounds between 
dibenzo(b,d) furan and imidazole also he evaluated in vitro antitumor activities and found 
to be more selective against Brest carcinoma (MCF-7) & myeloid liver carcinoma 
(SMMC-7721). 
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Sangita Chandra et al (2012) has evaluated the in vitro anti-inflammatory effect of 
aqueous extract of coffea arabica against the denaturation of protein concluded that 
coffee possessed marked in vitro anti-inflammatory effect against the denaturation of 
protein. The effect was plausibly due to the polyphenol content of coffee.  
Zhiping che and Hui Xu (2011) has reported an efficient one –pot synthesis of 
dibenzofuran, via SN Ar reaction of aryl halides and ortho bromo phenols in the presence 
of anhydrous K2CO3 and subsequent ligand free palladium-catalysed intramolecular aryl-
aryl cross coupling cyclization under microwave irradiation. In end it concluded that they 
got the product at maximum 72-96% yield in short reaction times. 
Srinivas kantevari et al (2011) reported a series of `noval dibenzo(b,d) furan and 
9-methyl-9H-carbazole derived hexa hydro-2H-pyrano(3,2-c)quinolines via povarov 
reaction(imino diels-alder reaction) and evaluated for their invitro anti-mycobacterial 
activity against M.tuberculosis H37Rv. 
N
H
O
Br
H
H
O
H
 
Lakshminarayana N et al (2010) reported a series of dibenzo(b,d) furan 
monocarboxylic acid derivatives and evaluated their ability to inhibit protein Tyrosin 
phosphate as potential anti diabetic agents. 
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O
N
S
O
OH
HOOC  
Perumal R et al (2008) have been synthesized pyrimidinoimidazolinones and 
evaluated for their antimicrobial activity. He observed that acceptable anti-inflammatroy 
activity by invitro model compared to standard diclofenac sodium. 
Bin wang et al (2006) has worked on a general synthetic route to 6,6-substituted-
6-H-dibenzo(b,d) pyran from dibenzofuran in good yield. The reaction undergoes 
reductive ring opening and cyclization. 
 
 
 
 
 
Katashi iota et al (1995) have been reported the chlorination of dibenzofuran and 
some of its derivatives also he concluded that preparation of 2-chloro dibenzofuran was 
accomplished most effectively by direct chlorination in presence of iron powder, 
dichlorination (2, 8-dichloro derivative) archived by the use of chlorine and iron powder. 
Barry reported 2-chloro (bromo) 7-aminodibenzofuran to completely inhibit 
M.Tuberculosis at a dilution of 1/4,00,000. 
O
NH2
X
 
 
O
O
CH2 CH3
R
2
R
1
Li,TMEDA
ether reflux
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AIM OF THE WORK 
 Today’s system of medicine has adopted highly sophisticated technological tools 
and discovered newer modern drugs. However beyond those success these drugs causes 
serious side effect also. That may be due to its reaction with cellular component of human 
system (tissues). In view of that the present work was aimed to synthesis some 
dibenzofuran-1,3-thiazole carboxamide derivatives by four step reactions with the 
substitution of various aromatic amines under suitable catalyst. All the synthesized 
compounds were characterized by physical, chemical and spectral data. Those 
synthesized compounds were further screened mainly for preliminary anti-inflammatory 
study and focused for further pharmacological evaluation.      
The total plan of the work as follows 
 The literature review done with the help of journals, scifinder, online sites and 
some books.   
 To synthesize some dibenzofuran 1,3-thiazole  carboxamide derivatives. 
 Ten derivatives were synthesised by substituting aryl amine with suitable catalyst 
and solvents. 
 The purity and progress of the reactions will be monitored by TLC with suitable 
solvent system. 
 The purification of the compounds will be carried by purification methods like 
recrystallization by using suitable solvents. 
 To characterize the structures of newly synthesized compounds by IR, 1H NMR 
and Mass spectra. 
  The anti-inflammatory activity of synthesised compounds done by protein 
denaturation assay method. 
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PLAN OF WORK 
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 SYNTHESIS AND EXPERIMENTAL PROCEDURE 
 Materials and Methods 
 The melting points were taken in open capillary tube and are 
uncorrected. The IR spectra of the compounds were recorded on FT-IR spectrometer-
4100 typeA with potassium bromide pellets. The 
1
H-NMR and spectra of the 
synthesized compounds were recorded on a JOEL 500 MHz NMR spectrometer in 
CHCl3 / DMSO. Mass spectra were recorded on Shimadzu GCMS QP 5000. The 
purity of the compounds was checked by TLC on pre – coated SiO2 gel (HF254 200 
mesh) aluminum plates (E-merk) using ethyl acetate: n-hexane as eluent and 
visualized in UV- chamber.(Harbone JB 2005). The IR, 
1
H-NMR, and mass spectra 
were consistent with the assigned structure.  
 
 Synthetic Methods 
For the synthesis of substituted dibenzofuran carboxamide, at first 2-(4-
methoxydibenzo [b, d] furan-1-yl)-5-methyl-N-benzyl-1, 3-thiazole-4-carboxamide 
was prepared in four steps using 4-methoxy dibenzo [b, d] furan as a starting 
compound. In the first step, 4-methoxy dibenzo [b, d] furan gets converted to 4-
methoxydibenzo[b, d]furan -1-carbothiamide, in the second step next Ethyl 2-(4-
methoxydibenzo[b,d]furan-1-yl)-5-methyl-1,3-thiazole-4-carboxylate was obtained 
which in third step gets converted as carboxylic acid derivatives and then in fourth 
step we got 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-benzyl-1,3-thiazole-4-
carboxamide. Finally from the fourth step we produced series of ten aryl amine 
derivatives and the detailed procedures and scheme are given below.(Gopal B et al 
2012).  
O
O
CH3
4-methoxydibenzo[b,d]furan
O
O
CH3
S
NH2
O
O
CH3
S
N
CH3
O
O CH3
O
O
CH3
S
N
CH3
O
OH
NH2
R
O
O
CH3
S
N
CH3
O
NH
R
(1) (2)
(3)
(4 - 4i)  
                                                   Fig.:3 
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Synthesis of 4-methoxydibenzo [b, d] furan-1-carbothioamide (1) 
4-methoxy dibenzo[b,d]furan 1 g, (5.05 mmol) in 11 ml of methane sulfonic 
acid was taken in a round bottom flask then 1 g potassium thiocyanate was added  
(10.29 mmol) slowly, the reaction was kept at 0–5 ° C in ice and salt mixture, after 
the addition the reaction mass was stirred at room temperature. Finally the mixture 
was poured into crushed ice and the solid obtained was filtered. It was triturated with 
n-hexane and dried to get a pale brown coloured solid (0.9 g). Yield—70%; mass m/z: 
258.2 (M+1). 
Synthesis of Ethyl 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-1,3-thiazole-4-
carboxylate (2) 
   4-methoxydibenzo [b, d] furan-1-carbothioamide (1.0 mmol) was taken with 
5ml ethanol and stirred to become a solution, then potassium carbonate (1.5 mmol) 
followed by ethyl 3-bromo-2-oxobutanoate (1.2 mmol) was added at room 
temperature. The reaction mixture was refluxed at 80°C for 2 hr with occasional 
shaking, subsequently it was poured into 25 ml of cold water and the precipitate 
which obtained was filtered to get a peach coloured solid, yield - 50%; mass m/z: 
354.1 (M+1). 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-1,3-thiazole-4-
carboxylic acid (3) 
 To a slurry of ethyl 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-1,3-
thiazole-4-carboxylate (50 mg,0.116 mmol) in ethanol (5 mL) was added potassium 
hydroxide (30 mg, 0.535 mmol) followed by water (0.5 mL) and the mass was stirred 
at rt for 2 h. Subsequently the reaction mixture was poured into cold water, acidified 
with 1 N HCl to a pH of 3–4; and the precipitated solid was filtered and triturated 
with ether followed by n–hexane to give a off-white solid; Yield—42% m/z: 403.1 
(M+1).  
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-benzyl-1,3-thiazole-4-
carboxamide (4) 
 In a 50ml round bottom flask 0.2 g (0.00048mol) of 2-(4-methoxydibenzo 
[b,d]furan-1-yl)-5-methyl-1,3-thiazole-4-carboxylic acid  was dissolved in 10ml 
dichloromethane. To that solution 0.32g (0.00096 mol) TBTU and 0.15 ml (0.0014 
mol)Triethylamine  was added and stirred for 5 min under nitrogen atmosphere. Then 
benzyl amine  (0.632 mmol) was added and stirred for 3hr under room temperature. 
The completion of the reaction was monitored by TLC and the reaction mixture was 
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extracted with ethyl acetate. The organic layer was washed with sodium bicarbonate 
solution, water, brine solution, which was separated and dried over anhydrous sodium 
sulphate. The evaporation of solvent yielded the target compounds. 0.13g, Yield: 
76%. m/z: 429.1 (M+1).(Katashi O et al 1955.) 
 
OOCH3
S
N
CH3
NH
O
R
 
General structure   
Table :.1  
S.No Code R IUPAC Name M.P 
°C 
Yield 
% 
1 4 NH2
  
2-(4-methoxydibenzo(b,d)furan-1-yl)-5-methyl-n-
benzyl-1,3-thiazole-4-carboxamide  
192 76 
2 4a  
NH2
H3CO  
2-(4-methoxydibenzo(b,d)furan-1-yl)-5-methyl-n-(4-
methoxybenzyl)-1,3-thiazole-4-carboxamide  
152 79.13 
3 4b NH2
Cl
Cl   
2-(4-methoxydibenzo(b,d)furan-1-yl)-5-methyl-N-
(3,4-dichlorobenzyl)1,3thiazole-4-carboxamide  
164 61.26 
4 4c 
NH2
Cl
  
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
(2chlorobenzyl)-1,3-thiazole-4-carboxamide  
120 55.46 
5 4d NH2
F  
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
(4-fluorobenzyl)-1,3-thiazole-4-carboxamide  
194 59.21 
6 4e NH2
Cl  
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
(4-chlorobenzyl)-1,3-thiazole-4-carboxamide  
182 54.04 
7 4f NH2
F3C
CF3  
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
[(3,5-bis tri fluoro methyl)benzyl]-1,3-thiazole-4-
carboxamide 
198 71.90 
8 4g NH2
F3C  
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
[(4-tri fluoro methyl)benzyl]-1,3-thiazole-4-
carboxamide 
184 72.16 
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9 4h NH2
OCH3  
 
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
(3-methoxybenzyl)-1,3-thiazole-4-carboxamide 
170 83.24 
10 4i 
N
NH2
 
2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-
(pyridine-3-yl)-1,3-thiazole-4-carboxamide 
226 87.83 
  
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(4-
methoxybenzyl)-1,3-thiazole-4-carboxamide(4a) 
OOCH3
S
N
CH3
NH
O
O
CH3
 
 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(3,4-
dichlorobenzyl)-1,3-thiazole-4-carboxamide(4b) 
OOCH3
S
N
CH3
NH
O
Cl
Cl
 
 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(2chlorobenzyl)-
1,3-thiazole-4-carboxamide(4c) 
OOCH3
S
N
CH3
NH
O
Cl
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Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(4-fluorobenzyl)-
1,3-thiazole-4-carboxamide(4d) 
OOCH3
S
N
CH3
NH
O
F
 
 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(4-chlorobenzyl)-
1,3-thiazole-4-carboxamide(4e) 
OOCH3
S
N
CH3
NH
O
Cl
 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-[(3,5-
bistrifluoromethyl)benzyl]-1,3-thiazole-4-carboxamide(4f) 
OOCH3
S
N
CH3
NH
O
F
F
F
F
F
F
 
 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-[(4-
trifluoromethyl)benzyl]-1,3-thiazole-4-carboxamide(4g) 
OOCH3
S
N
CH3
NH
O
F
F
F
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Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(3-
methoxybenzyl)-1,3-thiazole-4-carboxamide(4h) 
OOCH3
S
N
CH3
NH
O
O
CH3
 
 
Synthesis of 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(pyridine-3-yl)-
1,3-thiazole-4-carboxamide(4i) 
OOCH3
S
N
CH3
NH
O
N
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PHYSICO-CHEMICAL PROPERTIES AND SPECTRAL DATA OF THE 
SYNTHESISED COMPOUNDS (Mc MURRY J 1992). 
       Table:2. Physical data of compound - 4 
 
OOCH3
S
N
CH3
NH
O
 
 
Compound 4 
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-benzyl-1,3-
thiazole-4-carboxamide 
Molecular 
formula 
C25H20 N2 O3 s 
Molecular  weight 428 
M.P. 192
0
C 
Yield ( % ) 76 
IR (KBr),ν (cm-1) 3415 N-H bend (amide), 3476 C=C-H. (Ar carbon), 1741, C=O stretch  (carbonyl 
amide), 1624 – 1446 C=C stretch (Ar ring),1018 C-N stretch (amine) 799 (Para 
substitution) 
1
H-NMR  δ (ppm) 1H-NMR (500 MHz, CDCl3) ppm: 2.97 (s, 3H, CH3); 4.11 (s, 3H, OCH3);  4.64 - 
4.65 (d, 2H, CH2); 6.97-7.03 (m, 2H, Ar-H); 7.29 (m, 1H, Ar-H); 7.33 – 7.39 (m, 
4H, Ar-H); 7.43 (t, 1H, Ar-H); 7.48 - 7.50 (d, 1H, Ar-H); 7.62 - 7.63 (d, 1H, Ar-
H); 7.90 - 7.92 (t, 1H, Ar-H); 8.38 – 8.40(d, 1H, N-H). 
HRMS (m/z): 429(M
+1
) 
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Figure:4. Infrared spectra of compound – 4 
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Figure:5. NMR spectra of compound – 4 
 
 
Figure:6. Mass spectra of compound – 4 
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Table:3. Physical data of compound – 4a 
 
OOCH3
S
N
CH3
NH
O
O
CH3
 
Compound 4a           
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(4-
methoxybenzyl)-1,3-thiazole-4-carboxamide 
Molecular  formula C26H22 N2 O4 s 
Molecular  weight 458 
M.P. 152
0
C 
Yield ( % ) 79.13 
IR (KBr),ν (cm-1) 3413 N-H bend (amide), 3473 C=C-H. (Ar carbon), 1740 C=O stretch  (carbonyl 
amide), 1625 – 1454 C=C stretch (Ar ring),1021 C-N stretch (amine) 787,754 
(Para substitution) 
1
H-NMR  δ(ppm) 1H-NMR (500 MHz, CDCl3) ppm: 2.96 (s, 3H, CH3); 3.80 (s, 3H, OCH3);  4.11 
(s, 3H, OCH3);  4.57 - 4.58 (d, 2H, CH2); 6.87- 6.88 (d, 2H, Ar-H); 7.00 - 7.03 
(m, 2H, Ar-H); 7.29 – 7.31 (m, 2H, Ar-H); 7.44 (t, 1H, Ar-H); 7.48 - 7.49 (d, 1H, 
Ar-H); 7.62 - 7.63 (d, 1H, Ar-H); 7.83 - 7.85 (t, 1H, Ar-H); 8.37 – 8.39 (d, 1H, 
N-H). 
HRMS (m/z):  459(M
+1
) 
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Figure:7 Infrared spectra of compound – 4a 
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Figure:8 NMR spectra of compound – 4a 
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Figure:9 Mass spectra of compound – 4a 
 
 
 
Table:4. Physical data of compound – 4b 
 
OOCH3
S
N
CH3
NH
O
Cl
Cl
 
 
Compound 4b            
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(3,4- di chloro 
benzyl)-1,3-thiazole-4-carboxamide 
Molecular  formula C25H18 Cl2N2 O3 s 
Molecular  weight 497 
M.P. 164
0
C 
Yield ( % ) 61.26 
IR (KBr),ν (cm-1) 3414 N-H bend (amide), 3474 C=C-H. (Ar carbon), 1740 C=O stretch (carbonyl 
amide), 1627 – 1464 C=C stretch (Ar ring),1165,1130 (Ar-Cl stretch), 1019 (C-N 
stretch amine), 791 (Para substitution), 744(ortho substitution). 
1
H-NMR  δ(ppm) 1H-NMR (500 MHz, CDCl3) ppm: 2.95 (s, 3H, CH3); 4.11 (s, 3H, OCH3);  4.57 - 
4.59 (d, 2H, CH2); 7.01 - 7.04 (m, 1H, Ar-H); 7.08 - 7.12 (t, 1H, Ar-H); 7.21 - 
7.23 (m, 1H, Ar-H);  7.40 – 7.42 (d, 1H, Ar-H); 7.46 - 7.51 (m, 3H, Ar-H); 7.64 - 
7.66 (d, 1H, Ar-H); 7.94 - 7.97 (t, 1H, Ar-H); 8.34 – 8.35 (d, 1H, N-H). 
HRMS (m/z):  495(M
-1
) 
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Figure:10 Infrared spectra of compound – 4b 
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Figure:11 NMR spectra of compound – 4b 
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Figure:12 Mass spectra of compound – 4b 
 
Table:5. Physical data of compound – 4c 
 
OOCH3
S
N
CH3
NH
O
Cl
 
 
Compound 4c         
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(2chlorobenzyl)-
1,3-thiazole-4-carboxamide 
Molecular  formula C25H19 Cl N2 O3 s 
Molecular  weight 462 
M.P. 120
0
C 
Yield ( % ) 55.46 
IR (KBr),ν (cm-1) 3414 N-H bend (amide), 3474 C=C-H. (Ar carbon), 1740 C=O stretch  
(carbonyl amide), 1627 – 1450 C=C stretch ( Ar ring),1131(Ar-Cl stretch), 1047 
C-N stretch (amine), 785 (Para substitution), 753(ortho substitution). 
 HRMS (m/z):  463 (M
+1
) 
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Figure:13 Infrared spectra of compound – 4c 
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Figure:14 Mass spectra of compound – 4c 
 
Table:6. Physical data of compound – 4d 
 
OOCH3
S
N
CH3
NH
O
F
 
Compound 4d          
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(4-fluorobenzyl)-
1,3-thiazole-4-carboxamide 
Molecular  formula C25H19 F N2 O3 s 
Molecular  weight 446 
M.P. 194
0
C 
Yield ( % ) 59.21 
IR (KBr),ν (cm-1) 3415 N-H bend (amide), 3473 C=C-H. (Ar carbon), 1740 C=O stretch  (carbonyl 
amide), 1627 – 1450 C=C stretch (Ar ring),1098 (C-F stretch), 1014 C-N stretch 
(amine), 799 (Para substitution). 
HRMS (m/z): 447 (M
+1
) 
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Figure:15 Infrared spectra of compound – 4d 
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Figure:16 Mass spectra of compound – 4d 
 
Table:7. Physical data of compound – 4e 
 
OOCH3
S
N
CH3
NH
O
Cl
 
Compound 4e        
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(4-chlorobenzyl)-
1,3-thiazole-4-carboxamide 
Molecular formula C25H19 Cl N2 O3 s 
Molecular  weight 462 
M.P. 182
0
C 
Yield ( % ) 54.04 
IR (KBr),ν (cm-1) 3414 N-H bend (amide), 3474 C=C-H, (Ar carbon), 1740 C=O stretch  (carbonyl 
amide), 1636 – 1448 C=C stretch (Ar-C),1133 (Ar-Cl  stretch), 1014 C-N stretch 
(amine), 799 (Para substitution). 
HRMS (m/z): 463(M
+1
)  
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Figure:17 Infrared spectra of compound – 4e 
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Figure:18 Mass spectra of compound – 4e 
 
Table:.8 Physical data of compound – 4f  
 
OOCH3
S
N
CH3
NH
O
CF3
F3C
 
Compound 4f  
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-[(3,5-bis tri 
fluoro methyl)benzyl]-1,3-thiazole-4-carboxamide 
Molecular  formula C27H18 F6 N2 O3 s 
Molecular  weight 564 
M.P. 198
0
C 
Yield ( % ) 71.90 
IR (KBr),ν (cm-1) 3474N-H bend (amide), 3550 C=C-H (Ar carbon), 1740 C=O stretch  (carbonyl 
amide), 1627 – 1448 C=C stretch (Ar ring),1172,1121(CF3 stretch), 1014 (C-N 
stretch amine),  802 (Para substitution), 899 (Meta Substitution). 
 HRMS (m/z): 563 (M
-1
) 
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Figure:19 Infrared spectra of compound – 4f 
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Figure:20 Mass spectra of compound – 4f 
 
Table:9 Physical data of compound – 4g 
 
OOCH3
S
N
CH3
NH
O
CF3
 
Compound 4g   
 
 
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-[(4-tri fluoro 
methyl)benzyl]-1,3-thiazole-4-carboxamide 
Molecular formula C26 H19 F3 N2 O3 s 
Molecular  weight 496 
M.P. 184
0
C 
Yield ( % ) 72.16 
IR (KBr),ν (cm-1) 3414 N-H bend ( amide), 3472 C=C-H. (Ar carbon), 1740 C=O stretch (carbonyl 
amide), 1639 – 1446 C=C stretch (Ar ring),1162 (CF3 stretch), 1016 (C-N 
stretch (amine), 798 (Para substitution). 
HRMS (m/z): 495(M
-1
) 
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Figure:21 Infrared spectra of compound – 4g 
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Figure:22 Mass spectra of compound – 4g 
 
Table:10 Physical data of compound – 4h 
 
OOCH3
S
N
CH3
NH
O
O
CH3
 
Compound 4h 
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(3-
methoxybenzyl)-1,3-thiazole-4-carboxamide 
Molecular  formula C26H22 N2 O4 s 
Molecular  weight 458 
M.P. 170
0
C 
Yield ( % ) 83.24 
IR (KBr),ν (cm-1) 3415 N-H bend (amide), 3474(C=C-H (Ar carbon), 1740 C=O stretch  (carbonyl 
amide), 1641 – 1448 C=C stretch (Ar ring), 1015 C-N stretch (amine), 877 (Meta 
substitution). 
HRMS (m/z): 459(M
+1
) 
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Figure:23 Infrared spectra of compound – 4h 
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Figure:24 Mass spectra of compound – 4h 
 
Table:11 Physical data of compound – 4i 
 
OOCH3
S
N
CH3
NH
O
N
 
Compound 4i 
IUPAC NAME 2-(4-methoxydibenzo[b,d]furan-1-yl)-5-methyl-N-(pyridine-3-yl)-
1,3-thiazole-4-carboxamide 
Molecular  formula C24H19 N3 O3 s 
Molecular  weight 429 
M.P. 226
0
C 
Yield ( % ) 87.83 
IR (KBr),ν (cm-1) 3414N-H bend (amide), 3477 C=C-H. (Ar carbon), 1740 C=O stretch  
(carbonyl amide), 1643 – 1449 C=C stretch (Ar ring),1016 C-N stretch 
(amine). 
1
H-NMR  δ (ppm) 1H-NMR (500 MHz, CDCl3) ppm: 2.84 (s, 3H, CH3); 4.06 (s, 3H, OCH3);  
4.51 - 4.52 (d, 2H, CH2); 7.20 -7.23 (t, 1H, Ar-H); 7.30 (d, 1H, Ar-H); 7.42 – 
7.43 (m, 1H, Ar-H); 7.57 – 7.58 (t, 1H, Ar-H); 7.64 - 7.65 (d, 1H, Ar-H); 7.76 
- 7.77 (d, 1H, Ar-H); 7.80 - 7.82 (d, 1H, Ar-H); 8.47 - 8.51 (d, 2H, Ar-H); 
8.64 (s, 1H, Ar-H), 8.93 - 8.96 (t, 1H, N-H). 
  HRMS (m/z):  430(M
+1
) 
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Figure:25 Infrared spectra of compound – 4i 
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Figure:26 NMR spectra of compound – 4i 
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Figure:27 Mass spectra of compound – 4i 
 
                                                              EVALUATION OF ANTI-INFLAMMATORY ACTIVITY  
 
J.K.K.Nattraja College of Pharmacy Page 49 
 
 Evaluation of in vitro anti-inflammatory activity 
Introduction  
Inflammation is a bodily response to injury, infection or destruction 
characterized by heat, redness, pain, swelling and disturbed physiological functions. 
Inflammation is a normal protective response to tissue injury caused by physical 
trauma, noxious chemical or microbial agents. It is triggered by the release of 
chemical mediators from injured tissues and migrating cells. The present study was 
focused to evaluate the possible in vitro anti-inflammatory effect of synthesized 
compounds against the denaturation of protein.(Heendeniya SN et al 2018). 
Anti-denaturation assay method  
 The denaturation of protein as one of the causes as inflammation is 
well documented. Production of auto-antigen in certain rheumatic diseases may be 
due to in vivo denaturation of proteins. A number of anti inflammatory drugs are 
known to inhibit the denaturation of protein. Based on that we have employed protein 
denaturation as in vitro screening model for anti-inflammatory compounds.(Sangita C 
et al 2012). 
Procedure  
The experiment was carried out with minor modification. The standard drug 
and extract was dissolved in minimum quantity of Dimethyl Formamide (DMF) and 
diluted with phosphate buffer (0.2 M, PH 7.4). Final concentration of DMF in all 
solution was less than 2.5%. Test Solution (4ml) containing different concentrations 
of drug was mixed with 1 ml of 1mM albumin solution in phosphate buffer and 
incubated at 37°C in incubator for 15 min. Denaturation was induced by keeping the 
reaction mixture at 70°C in water bath for 15 min. After cooling, the turbidity was 
measured at 660 nm. Percentage of Inhibition of denaturation was calculated from 
control where no drug was added. The diclofenac sodium was used as standard drug. 
The percentage inhibition of denaturation was calculated by using following 
formula.(Banerjee M et al 2011) 
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           (A Test – A Control)   
 Percentage of inhibition = x100              
            (A Test ) 
At = O.D. of test solution 
Ac = O.D. of control 
 
Table :12  Anti inflammatory activity of Compounds (4 - 4i)  
 
Compound 
code 
Concentrations in µg/ml 
100 200 300 400 500 1000 
4 4.06 21.85 43.26 49.57 63.91 80.30 
4a 7.08 8.52 26.70 29.76 35.16 51.63 
4b 9.92 29.34 44.07 46.11 58.59 71.77 
4c 26.70 44.60 61.68 66.85 72.99 80.36 
4d 35.86 54.96 70.71 76.30 79.37 89.06 
4e 27.16 30.99 47.08 51.83 52.61 67.03 
4f 27.60 28.91 46.11 47.08 48.91 65.49 
4g 38.54 44.60 62.30 64.98 66.85 79.96 
4h 32.57 41.87 52.03 63.00 67.58 78.38 
4i 5.60 7.08 9.92 14.49 29.76 59.16 
Diclofinac 
sodium 
25.31 51.44 64.77 72.49 77.22 84.94 
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Fig:28 
 
Photocopies representing anti inflammatory activity screening 
Synthesised of compound 4 (Fig.29) 
 
Synthesised of compound 4a (Fig.30) 
 
 
 
                                                              EVALUATION OF ANTI-INFLAMMATORY ACTIVITY  
 
J.K.K.Nattraja College of Pharmacy Page 52 
 
Synthesised of compound 4b (Fig.31) 
 
Synthesised of compound 4c (Fig.32) 
 
Synthesised of compound 4d (Fig.33) 
 
Synthesised of compound 4e (Fig.34) 
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Synthesised of compound 4f (Fig.35) 
 
Synthesised of Compound 4g (Fig.36) 
 
Synthesised of Compound 4h (Fig.37) 
 
Synthesised of Compound 4i (Fig.38) 
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Std Diclofenac Sodium (Fig.39) 
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RESULTS AND DISCUSSION 
The dibenzofuran carboxamide, a well known derivative. It has been synthetically 
prepared in four step procedure. In the first step methoxydibenzofuran was converted in 
to methoxydibenzofuran carbothiamide and in second methoxydibenzofuran 
carrboxylate. Next in third methoxydibenzofuran carboxylic acid and finally in to a 
methoxydibenzofuran carboxamide as a parent compound. The introduction of aryl amine 
groups in to the aforesaid parent molecule was done by coupling reaction. 
The purity of all the synthesized derivatives was confirmed by melting point, thin 
layer chromatography and FTIR spectroscopy mainly. In addition to that 
1
H NMR, Mass 
spectra studies were also done with most of the compounds. The yields of all the 
synthesized compounds were between 54-87%. All the derivatives were non-
hygroscopic. 
Different spectral data of the derivatives were taken in to the consideration. Thus 
the IR absorbtion band at 3413 to 3474cm
-1
 and 1740 to 1741 cm
-1 
showed the presence 
of N-H bend (amide) and C=O stretch (carbonyl amide) group respectively also 1098 to 
1133cm
-1
 are indicate Ar – Cl stretch, 3473 to 3550 cm-1 are C=C-H of aromatic 
compound, 1636 -1446 cm
-1 
for C=C stretch of aromatic ring. Benzen substitution pattern 
confirmed for ortho (741-753 cm
-1
) meta (899 cm
-1
) and para (754 - 799 cm
-1
) positions 
too. The 
1
H NMR spectra of the selected derivatives showed the expected integration and 
peak multipilicites. In all the derivatives a typical singlet at δ 8.34 -8.96 was observed 
that was assigned to the N-H protons. The aromatic protons were present in the region of 
δ 6.87-8.69 respectively and the methyl, methoxy substitution of each compound were at 
δ 2.84 -2.97, δ 3.80 - 4.11 region in the decreasing order. The Mass spectra of all the 
derivatives were recorded and the suggested formulae were confirmed by the respective 
molecular ion peaks. 
  Anti-inflammatory activity of the synthesized compounds were studied by 
protein denaturation assay method and the results of such studies leading ultimately to 
their percentage inhibition values have been reported in tables and graphs. 
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All the synthesized compounds were capable of moderate inhibition effect. 
Among these compounds 4c, 4d, 4e, 4f, 4g and 4h showed promising activity when 
compared to STD drug diclofenac sodium at low concentration (100 µg/ml) and the 
percentage of inhibition are found to be 35.86, 26.70, 27.16, 27.60, 38.54 and 32.57 
µg/ml respectively. Where STD drug diclofenac sodium was 25.31 µg/ml. particularly 
the compound 4d shows very good inhibiting property at all concentrations when 
compared to the standard drug. 
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SUMMARY AND CONCLUSION 
The present work entitled “studies on synthesis, characterization and biological 
activity methoxydibenzofuran-1,3-thiazole carboxamide derivatives”, has described the 
synthesis of ten compounds. It is well established that the presence of 
dibenzofuranthiazole in molecules has resulted in pharmacologically and biologically 
active agents these are having a varied type of heterocyclic or otherwise, straight chain 
structures. Many of the existing drugs, for example, Tetomilast, oglemilast and 
ciliomilast are potent anti-inflammatory agents, they do have serious side effects. These 
include nausea, emesis and gastric acid secretion. Many other standard drugs of today 
also, have other types of unwanted effects one important being drug resistance. Thus, 
newer agents with out such undesirable side effects and better potency are the need of the 
day. This work, thus, was undertaken to study a few new compounds.  
Based on the literature survey tetomilast a PDE inhibitor from otsuka contain 
thiazole moiety in it and oglemilast contain a new series of dibenzofuran nucleus, also the 
cilomilast carrying aryl derivatives with the conclusion  in mind we forwarded to 
synthesis dibenzofuran thiazole carboxamide derivatives. All the compounds were 
prepared in the laboratory and purified by crystallization with suitable solvents. 
Furthermore, all the structures of the compounds were confirmed by melting point, FTIR, 
1
H-NMR and High resolution Mass spectroscopy.   
The cyclic nucleotide phosphodiesterase are a family of enzyme that selectively 
catalyse the hydrolysis of cAMP and cGMP. The inhibition of the PDEs in the cell 
effectively elevates the intracellular cAMP level. This in turn inhibits the release of 
inflammatory mediators (TNF-α, interleukin-2, interleukin -12) and act as a anti 
inflammatory drug.(Banerjee M et al 2011) In view of that we focused the biological 
evaluation for all the synthesized compounds.  The results of short term in vitro anti-
inflammatory screening against protein denaturation method show a moderate inhibitory 
effect. Among these particularly compounds 4c, 4d, 4e, 4f, 4g and 4h showed promising 
activity when compared to standard drug diclofenac sodium at lowest concentration of 
100 µg/ml and the percentage of inhibition are found to be 26.70, 35.86, 27.16, 27.60, 
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38.54 and 32.57 µg/ml respectively. Where the standard drug diclofenac sodium was 
25.31 µg/ml. Particularly the compound 4d shows a very good inhibiting property at all 
concentrations (100 -1000µg/ml) when compared to the standard drug. This experiment 
suggest that the anti-inlammatory activity of dibenzofuranthiazole carboxamide 
derivatives mainly due to the halogenic derivative with para substitution. The fluro, 
chloro substitution was one of the key groups to enhance greatly the activity with para 
and ortho substituent, as well as the methoxy derivatives with meta substituent also 
shows moderate activity.  
 
                                                                                                                     REFERENCES 
 
J.K.K.Nattraja College of Pharmacy Page 59 
 
REFERENCES 
  
Ananthi R., Tinabaye A., Ganesan T., Selvaraj G., (2016).Antimicrobial and anti-
inflammatory activity of usnic acid and its acetyl derivative usnic acid 
diacetate.International And Journal Of Scientific&Engineering Research 7(8),39-44. 
Ashok D., SreeKanth S., Sarasija M., Vijiulatha M., (2017).Synthesis biological 
evalution and molecular docking of spirofurochromanone derivative as anti-inflammatory 
and anti oxidant agents.Royal Society of Chemistry 7,25710-25724. 
Banerjee M., Sundeepp H.K., Sahu S.K., Das A., (2011).Synthesis and invitro protein 
denaturation screening of novel substituted Isoxazole/Pyrazole derivatives.Rasayan.J. 
Chem 4(2),413-417. 
Bin Wang., Minxiong Li., Shansheng Xu., Haibin Song., (2006).A general synthetic route 
to 6,6-substituted 6H-dibenzo(b,d)pyrans from dibenzofuran.Journal of Organic 
Chemistry71,8291-8293. 
Book. 1
st 
Edn, Universities Press Pvt. Ltd., 26-30. 
Gopal B., Sukunath N., Lavanya A., Thirunavukarasu S., (2016).Invivo effective 
dibenzo(b,d)furan-1-yl-thiazoles as novel PDE-4 inhibitors.Bioorganic &Medicinal 
Chemistry 24,5702-5716. 
 Gurdeep  R  Chatwal.,  Sham  K  Anand (2003) Instrumental  methods  of  chemical 
Analaysis. 5
th 
revised Edn. Mumbai, Himalaya publishing house  2, 567. 
Harborne JB., (2005). Phytochemical Methods. A guide to modern techniques of plant 
analysis. 3
rd 
Edn, Springer (India) Pvt. Ltd. New Delhi. 5-16, 22. 
Heendeniya SN., Ratnasooriya WD., Pathiraana RN., (2018). Invitro investigation of 
anti-inflammatory activity and evaluation of phytochemical profile of syzygium 
caryophyllatum.Journal Of Pharmacognosy And Phyto Chemistry7(1),1759-1763. 
Jayakar B., (2010). In vitro antioxidant evaluation of Pseudarthria viscid. International 
Journal of current pharmaceutical research 2, 21-23. 
Ji Young C., Geum B., Eun Jin Cho., (2018).Visible-light-promoted synthesis of Dibenzo 
furan derivatives.The journal of Organic Chemistry 83,805-811. 
Katashi O., Johnson G., Henry G., (1955).The Cholrination of dibenzofuran and some 
of its derivatives.Journal of Am. Chem.Soc.,20,657-664. Venkateswaramurthy N., 
(2010).Invitro  cytotoxic  effect  of  ethanolic  extract  of Pseudarthria viscid. 
International Journal of Pharmacy and Pharmaceutical Sciences 2, 93-94. 
Khandelwal KR., Kokate CK., Pawar AP., Gokhale SB., (1996).Practical Pharmacognosy 
                                                                                                                     REFERENCES 
 
J.K.K.Nattraja College of Pharmacy Page 60 
 
Techniques and Experiments. Nirali Prakashan 3
rd 
Edn. 165-166. 
 Kokate CK., Gokhale SB (2001) Pharmacognosy. Pune, Nirali Prakashan. 16
th 
Edn 
134. 
 Krishnaswamy NR.(2003) Chemistry of Natural Products. A Laboratory hand 
Lakshminarayana N., Rajendra Prasd Y., Laxmikant G., Abraham T., (2010).Synthesis 
and evaluation of some novel dibenzo(b,d)furan carboxylic acid as potential anti diabetic 
agents.European Journal Of Medicinal Chemistry 45,3709-3718. 
Lan-Xing L., Xue-Quan W., Ju-Ming Y., Yan Li., (2013).Synthesis of antitumour 
activities of novel dibenzo (b,d)furan imidazole hybrid compounds.European Journal Of 
Medicinal Chemistry 66,423-437.  
 Masirkar J., Deshmukh VN., Jadhav JK., and  Sakarkar DM., (2008).Anti-diabetic 
activity of the ethanolic extract of Pseudarthria viscida root against alloxan induced 
diabetes in albino rats. Indian Journal of Natural Products., 1, 541-542. 
McMurry,J.,1992. Organic Chemistry, 3
rd
 ed, Brooks/cole.,549-550. 
McMurry,J.,1992. Organic Chemistry, 4th ed, Brooks/cole.,549. 
 Meena AK., Rao MM., Ajit  Kandale., Sannd R., Kiran., (2010).Standardisation  of  
Desmodium  gangeticum.  A  Traditional  ayurvedic  Plant Drug Invention 2, 182-184. 
 Mohammed Ali. (2001) Objective type Pharmacy. 2
nd  
Ed. Delhi, Birla publication 
567-568. 
Nakanishi,K,1964.Infrared Absorption Spectroscopy,Holden Day.,27. 
Perumal R., Akalanka D., Manavalan R., Kalyani P., (2008).Inhibition of albumin 
denaturation and Anti-inflammatory activity of furfuryl substituted 
Pyrimidinomidazolinones.International Journal of Chemistry Science 6 (4),2016-2022. 
Sana T.,  Ozair A., Mohd A., (2018).Synthesis,anti-inflammatory,p38αMAP kinase 
inhibitory activities and molecular docking studies of quinoxaline derivatives containing 
triazole moiety.Bioorganic Chemistry 76,343-358. 
Sangita C., Priyanka C., Protapaditya D., Sanjib B., (2012).Evalution of invitro anti-
inflammatory activity of coffee against the denaturation of protein.Asian Pacific Journal 
of Tropical Biomedicine s178-s180. 
Srinivas K., Thirumal Y., Govardhan S., Balasubramanian., (2011).Synthesis of 
antitubercular evalution of novel dibenzo(b,d)furan and 9-methyl-9H-Carbazole derived 
hexahydro-2H-Pyrano(3,2-c)quinolones via povarov reaction.European Journal of 
Medicinal Chemistry 46,4827-4833. 
 Stahl E. Thin layer chromatography –A laboratory hand book. (1969) 2nd Ed Springer 
Pvt. Ltd., 1,694. 
                                                                                                                     REFERENCES 
 
J.K.K.Nattraja College of Pharmacy Page 61 
 
Thirumal Y., Jonnalagadda P., Perumal Y., Dharmarajan S., (2014).Rational design and 
synthesis of novel dibenzo(b,d)furan-1,2,3-triazole conjugates as potent inhibitors of 
Mycobacterium tuberculosis.European Journal of Medicinal Chemistry 71,160-167. 
Vinothkumar D., John Britto S., Sebastinraj J., Philip J Robinson and Senthilkumar S., 
(2009).Callus regeneration from stem explants of Pseudarthria viscid. African Journal 
of Biotechnology 8, 4048-4051. 
Ying Ma., Hui-Yu w., Yu-Ze Z., Hong L., (2017).Synthesis,bioactivity,3D-QSAR 
Studies of novel dibenzofuran derivatives as PTP-MEG 2 inhibitors.Oncotarget 8,38466-
38481. 
Zhen L., Hang  X., Ye Tian., Mengbi G., (2016).Design,Synthesis and Anti fungal 
activity of novel dibenzofuran-Triazole Hybrids.Molecules 21,732. 
 
 
